Joe Biden Diagnosed With Prostate Cancer
Analysis based on 45 articles · First reported May 18, 2025 · Last updated May 18, 2025
The diagnosis of Joe Biden with aggressive prostate cancer could lead to increased public awareness and potentially higher demand for cancer screening and treatment services, positively impacting healthcare and pharmaceutical companies. However, as a former president, the direct market impact is limited, primarily affecting sentiment around public health and potentially influencing political discourse.
Former United States President Joe Biden has been diagnosed with an aggressive form of prostate cancer, which has metastasized to his bones. The diagnosis, characterized by a Gleason score of 9 (Grade Group 5), was made after he experienced increasing urinary symptoms and a prostate nodule was found. His office stated that while the cancer is aggressive, it appears to be hormone-sensitive, allowing for effective management. Joe Biden and his family are currently reviewing treatment options with his physicians. This news comes months after Joe Biden left office in January.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard